Max Levin

8PUBLICATIONS
55CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCell physiologyCancer diagnosisStructural biology (incl. macromolecular modelling)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 09, 2026
PD-1 inhibitor-induced rheumatic, endocrine, and sarcoidosis-like immune-related adverse events in metastatic melanoma are associated with improved survival and lower corticosteroid exposure.

Maria Lindén, Hifaa Al Remawi, Anna Fager

|Aug 08, 2025
Immune-related hepatitis and hypophysitis are associated with superior survival in melanoma patients treated with combined ipilimumab and nivolumab.

Hifaa Al Remawi, Maria Lindén, Zhiyuan Zhao

|Jun 28, 2023
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy.

Vasu R Sah, Henrik Jespersen, Joakim Karlsson

|Jan 30, 2023
Cardiac Plin5 interacts with SERCA2 and promotes calcium handling and cardiomyocyte contractility.

Mathieu Cinato, Ismena Mardani, Azra Miljanovic

|Dec 05, 2022
Noninvasive detection of any-stage cancer using free glycosaminoglycans.

Sinisa Bratulic, Angelo Limeta, Saeed Dabestani

|Jul 23, 2021
Glucosylceramide synthase deficiency in the heart compromises β1-adrenergic receptor trafficking.

Linda Andersson, Mathieu Cinato, Ismena Mardani

Pageof 2

Frequent Collaborators

2 joint publications

Mathieu Cinato

2 joint publications

Muhammad Arif

2 joint publications

Marcus Henricsson

2 joint publications

Matias Ekstrand